Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-22 @ 2:25 AM
Study NCT ID:
NCT05672251
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2023-01-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Organization: